Covered recipient · General Payments record
OLUGBENGA O AJE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$2,233.13
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $782.88 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $322.89 | 5 |
| Alkermes, Inc. | $233.00 | 2 |
| Janssen Pharmaceuticals, Inc | $74.62 | 3 |
| Indivior Inc. | $31.26 | 1 |
| ITI, Inc. | $27.29 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.55 | 1 |
| Almatica Pharma Inc. | $24.55 | 1 |
| Corium, Inc. | $22.87 | 1 |
| Lundbeck LLC | $21.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.72 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189384 | CMS |
| ABBVIE INC. | $21.99 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189386 | CMS |
| ABBVIE INC. | $125.00 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189388 | CMS |
| ABBVIE INC. | $125.00 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189390 | CMS |
| ABBVIE INC. | $23.18 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103189392 | CMS |
| Alkermes, Inc. | $110.95 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120455214 | CMS |
| Alkermes, Inc. | $122.05 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120455216 | CMS |
| Almatica Pharma LLC | $24.55 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137554555 | CMS |
| Corium, LLC | $22.87 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100186075 | CMS |
| Indivior Inc. | $31.26 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523161 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27.29 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143181463 | CMS |
| Janssen Pharmaceuticals, Inc | $24.86 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077980990 | CMS |
| Janssen Pharmaceuticals, Inc | $14.99 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077981196 | CMS |
| Janssen Pharmaceuticals, Inc | $34.77 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077980946 | CMS |
| Lundbeck LLC | $21.85 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145889822 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.55 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118849924 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.